Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Durvalumab (MEDI4736) in Combination With Vigil in Advanced Women's Cancers

NCT02725489 is registered in ClinicalTrials.gov with Mary Crowley Medical Research Center as lead sponsor.

NCT NCT02725489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02725489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Durvalumab (MEDI4736) in Combination With Vigil in Advanced Women's Cancers
Lead sponsor
Mary Crowley Medical Research Center
Phase
Phase 2
Overall status
Completed
Start date
June 3, 2016
Completion date
December 2, 2020
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical cancer, endometrial cancer, fallopian tube cancer, ovarian cancer, primary peritoneal carcinoma, uterine cancer